VFA
EGRX

Virtus Fund Advisers’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Virtus Fund Advisers’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,117
Closed -$31.7K – 115
2023
Q1 		$31.7K Buy
+1,117
New +$31.7K 0.22% 75